Lenovo Shares Surge Nearly 20 After Record Revenue and AI Revenue Doubles RInfra Reports 79 Decline in Q4 Net Profit to 918 Crore Appoints Vijesh Babu Thota as CEO AIRelated Layoffs May Not Boost Stocks as Expected Data Suggests Semiconductor Titans Hit 1 Trillion Samsung Ends Strike Micron Surges on AI Valuation Prediction Markets Signal Potential Fed Rate Hike by Mid2027 Snowflake Shares Surge on AWS Partnership and Upbeat Outlook Nathans Famous Q4 2024 Earnings EPS of 096 Reported Stock Edges Lower Red Violet Inc RDVT Q1 2026 Earnings EPS Surges 409 Above Estimates Amid Strong Operational Execution Kenvue Inc KVUE Q1 2026 Earnings Solid EPS Beat Drives Modest Share Uptick HomeTrust Bancshares Inc HTB Q1 2026 Earnings Strong EPS Beat Drives Positive Investor Sentiment MBIN Q1 2026 Earnings EPS Beat of 502 Surprises Analysts Yet Stock Declines Giftify Inc GIFT Q1 2026 Earnings NarrowerThanExpected Loss Lifts Sentiment Cardiol Therapeutics Inc CRDL Modestly Advances as It Holds Above Key Support Orrstown Financial Services ORRF Edges Higher With Measured Upside Potential Huachen AI Parking HCAI Drops 10 Testing Key Support as Selling Pressure Intensifies NPFD Edges Higher as Investors Steady Holdings Nuveen Variable Rate Preferred Income Fund NPFD Analysis National Bank Holdings NBHC Slips 094 as Regional Banking Sentiment Softens Companies Press Ahead with Prediction Market Investments Amid Regulatory Uncertainty Genprex GNPX Q1 2026 Earnings Continued RD Investment as Gene Therapy Pipeline Progresses Element Solutions Inc ESI Holds Near Support as Modest Decline Suggests Consolidation Phase Soleno Therapeutics SLNO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Refocuses on Clinical Milestones Carriage Services Inc CSV Q1 2026 Earnings Modest EPS Beat Amid Flat Revenue and Negative Stock Reaction CLRB Q1 2026 Earnings EPS Beat Signals Improved Cost Discipline Collegium Pharmaceutical Q1 2026 Earnings EPS Surpasses Estimates Amid Strategic Execution Accuray ARAY Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Stock Defies the Downturn PRTS Q1 2026 Earnings EPS Surprise of 4885 Despite Negative Earnings DRMA Q1 2026 Earnings NarrowerthanExpected Loss Marks Progress for ClinicalStage Biotech